1. Academic Validation
  2. FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy

FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy

  • Nat Commun. 2025 Feb 2;16(1):1274. doi: 10.1038/s41467-025-56633-z.
Na Zhang 1 Yang Meng 2 3 Song Mao 1 Huiling Ni 1 2 Canhua Huang 1 Licong Shen 1 Kun Fu 1 Lu Lv 1 Chunhong Yu 1 Piyanat Meekrathok 1 Chunmei Kuang 1 Fang Chen 1 Yu Zhang 1 Kai Yuan 4 5 6 7 8
Affiliations

Affiliations

  • 1 Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology & Department of Gynecology, Xiangya Hospital, Central South University, Changsha, 410000, China.
  • 2 Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China.
  • 3 School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China.
  • 4 Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology & Department of Gynecology, Xiangya Hospital, Central South University, Changsha, 410000, China. yuankai@csu.edu.cn.
  • 5 Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China. yuankai@csu.edu.cn.
  • 6 Furong Laboratory, Changsha, 410008, China. yuankai@csu.edu.cn.
  • 7 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410000, China. yuankai@csu.edu.cn.
  • 8 The Biobank of Xiangya Hospital, Central South University, Changsha, 410000, China. yuankai@csu.edu.cn.
Abstract

Protein O-GlcNAcylation is a post-translational modification coupled to cellular metabolic plasticity. Aberrant O-GlcNAcylation has been observed in many cancers including endometrial Cancer (EC), a common malignancy in women. However, clinical characterization of dysregulated O-GlcNAcylation homeostasis in EC and interrogating its molecular mechanism remain incomplete. Here we report that O-GlcNAcylation level is positively correlated with EC histologic grade in a Chinese cohort containing 219 tumors, validated in The Cancer Genome Atlas dataset. Increasing O-GlcNAcylation in patient-derived endometrial epithelial organoids promotes proliferation and stem-like cell properties, whereas decreasing O-GlcNAcylation limits the growth of endometrial Cancer organoids. CRISPR screen and biochemical characterization reveal that tumor suppressor F-box only protein 31 (FBXO31) regulates O-GlcNAcylation homeostasis in EC by ubiquitinating the O-GlcNAc transferase OGT. Downregulation of O-GlcNAcylation impedes EC tumor formation in mouse models. Collectively, our study highlights O-GlcNAcylation as a useful stratification marker and a therapeutic vulnerability for the advanced, poorly differentiated EC cases.

Figures
Products
Inhibitors & Agonists
Other Products